Adhera Therapeutics, Inc. Accretion Expense
Adhera Therapeutics, Inc. reported Accretion Expense of $92.00 thousand for the 12-month period ending 2011-12-31, per its 10-K filed 2014-07-22.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AccretionExpense · last filed 2014-07-22
- Adhera Therapeutics, Inc. accretion expense for the quarter ending 2011-12-31 was $0.00, a 100.00% decline year-over-year.
- Adhera Therapeutics, Inc. accretion expense for the quarter ending 2011-09-30 was $31.00K, a 6.06% decline year-over-year.
- Adhera Therapeutics, Inc. accretion expense for the quarter ending 2011-06-30 was $36.00K.
- Adhera Therapeutics, Inc. accretion expense for the quarter ending 2011-03-31 was $25.00K.
- Adhera Therapeutics, Inc. accretion expense for fiscal 2011 was $92.00K, a 31.85% decline from fiscal 2010.
- Adhera Therapeutics, Inc. accretion expense for fiscal 2010 was $135.00K.
| Period end | Accretion Expense 3 month | Accretion Expense 6 month | Accretion Expense 9 month | Accretion Expense 12 month |
|---|---|---|---|---|
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-07-22 | $31.00K derived: sum of 2 quarters · filed 2014-07-22 | $67.00K derived: sum of 3 quarters · filed 2014-07-22 | $92.00K 10-K · filed 2014-07-22 |
| 2011-09-30 | $31.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-12-05 | $67.00K derived: sum of 2 quarters · filed 2012-12-05 | $92.00K 10-Q · filed 2012-12-05 | $140.00K derived: sum of 4 quarters · filed 2012-12-05 |
| 2011-06-30 | $36.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-12-05 | $61.00K 10-Q · filed 2012-12-05 | $109.00K derived: sum of 3 quarters · filed 2012-12-05 | $142.00K derived: sum of 4 quarters · filed 2012-12-05 |
| 2011-03-31 | $25.00K 10-Q · filed 2012-12-05 | $73.00K derived: sum of 2 quarters · filed 2012-12-05 | $106.00K derived: sum of 3 quarters · filed 2012-12-05 | |
| 2010-12-31 | $48.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-10-10 | $81.00K derived: sum of 2 quarters · filed 2012-10-10 | $135.00K 10-K · filed 2012-10-10 | |
| 2010-09-30 | $33.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-10 | $87.00K 10-Q · filed 2011-11-10 | ||
| 2010-06-30 | $54.00K 10-Q · filed 2011-08-11 |